American Marconi Wireless News - CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement

SCOTTSDALE, AZ / ACCESS Newswire / March 27, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making waves in the booming health and wellness industry with the launch of its latest breakthrough product: Passion Fuel Cordyceps Complex. This cutting-edge supplement is designed to supercharge libido, enhance stamina, improve blood flow, and optimize overall performance, providing an all-natural solution for individuals looking to elevate their intimate and athletic experiences.

Each serving of Passion Fuel Cordyceps Complex delivers a potent 300mg dose of pure Cordyceps extract (150mg per pill, 2 pills per serving)-a revered medicinal mushroom known for its powerful adaptogenic properties. Backed by scientific research, Cordyceps has been shown to increase oxygen uptake, improve circulation, boost testosterone levels, and enhance endurance, making it a game-changer for those seeking peak physical and sexual performance.

"This launch is a major milestone for CBDL as we continue to expand our product line with high-demand, science-backed formulations," said Lisa Nelson, President & CEO of CBD Life Sciences Inc. "With the sexual wellness market projected to skyrocket past $125 billion, we are positioning ourselves at the forefront of an industry that is set to redefine natural health solutions. Passion Fuel Cordyceps Complex has the potential to generate significant revenue streams and open the door to lucrative partnerships in both the supplement and pharmaceutical sectors."

Unleashing the Power of Cordyceps for Peak Performance Passion Fuel Cordyceps Complex offers a wide range of benefits, including:

• Enhanced libido & improved erectile function - Naturally increases testosterone and supports sexual health.

• Boosted stamina & athletic performance - Increases ATP production, delivering sustained energy and endurance.

• Improved blood flow & circulation - Supports heart health and oxygenation for peak physical function.

• Optimized hormonal balance - Helps regulate cortisol and stress levels, fostering overall well-being.

• Increased energy & vitality - Fights fatigue and enhances metabolic efficiency for all-day performance.

A Strategic Move for Future Growth The release of Passion Fuel Cordyceps Complex aligns with CBDL's aggressive expansion strategy, tapping into an industry that continues to experience unprecedented demand. With the dietary supplement market exceeding $177 billion in 2023, CBDL is capitalizing on a golden opportunity to deliver premium, plant-based formulations that consumers trust.

As the company accelerates its growth trajectory, Passion Fuel Cordyceps Complex is set to be distributed across major online marketplaces, wellness retailers, and direct-to-consumer platforms. CBDL is also actively exploring strategic partnerships to bring this powerhouse supplement to new audiences globally.

About CBD Life Sciences Inc. CBD Life Sciences Inc. (OTC: CBDL) is a leader in the rapidly expanding health and wellness industry, specializing in cutting-edge CBD-based and plant-derived formulations. With a commitment to innovation and quality, CBDL continues to develop science-backed products designed to optimize health, performance, and longevity.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz

Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
[email protected]
4802091720

SOURCE: CBD Life Sciences, Inc.

View the original press release on ACCESS Newswire

C.Garcia--AMWN